Resources

Liver Disease Information

In Your Area

Help Fight Liver Disease

We rely upon donations to fund programs, and our chapters rely upon volunteers to run events. Please support us.

Donate | Volunteer


Contact Us

American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006

212-668-1000 Tel
212-483-8179 Fax

Home > About Us > Corporate Partnerships

Corporate Partnerships

Each year dozens of companies are getting involved with the American Liver Foundation through Sponsorship, Corporate Teams and Workplace Giving. These companies not only provide funding for programs, support services and research, but they are reaching their target audiences in their communities. Thank you to all of our Corporate Partners who are committed to fighting liver disease that affects one in ten Americans. You are making a difference!

How your company can get involved


National Corporate Partnerships:

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view career opportunities on Facebook (https://www.facebook.com/AbbVieCareers) or learn more about them on their LinkedIn (https://www.linkedin.com/company/abbvie) page.

AbbVie is the National Gold Sponsor of:



Salix Pharmaceuticals is a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. Salix is headquartered in Raleigh, North Carolina and is a specialty pharmaceutical company committed to advancing the treatment of many chronic gastrointestinal disorders. For more than 20 years, Salix has licensed, developed, and marketed innovative products to provide healthcare professionals and patients with solutions for the management of many chronic and debilitating conditions. Salix currently markets its product line through dedicated, specialty sales groups to U.S. healthcare providers in the areas of gastroenterology, hepatology, internal medicine, primary care, infectious disease, and allergy/immunology.

Salix is the National Gold Sponsor of:

_______________________________________________________________________

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Gilead was founded in 1987 in Foster City, California. Since then, it has grown to become one of the world’s largest biopharmaceutical companies, with more than 7,000 employees across six continents. Please visit www.gilead.com for more information, or connect with them on Twitter @GileadSciences or on their LinkedIn page here: https://www.linkedin.com/company/gilead-sciences.

Gilead is the National Silver Sponsor of:

_______________________________________________________________________

For 125 years, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.

Merck is the National Bronze Sponsor of:




Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada. Intercept's International headquarters are located in London. For more information about Intercept, please visit www.interceptpharma.com.

Intercept is the National Bronze Sponsor of:

Page updated: May 25th, 2017

 

末末末末末末末末 Begin Code for Siteimprove Analytics 末末末末